WO2021062063A1
|
|
Improved variants of tev protease for biotechnological applications
|
US2021071179A1
|
|
Mobile-crispri plasmids and related methods
|
WO2020257519A1
|
|
Bacteria-engineered to elicit antigen-specific t-cells
|
WO2020251973A1
|
|
Compositions and methods for rna interference
|
WO2020243200A1
|
|
Method for multiplexed detection of nucleic acids using spectrally encoded beads
|
WO2020243160A1
|
|
Methods and compositions for multiple-parameter single-cell analysis using spectrally encoded microbeads
|
WO2020223160A1
|
|
A novel chromatin-opening element for stable long term gene expression
|
WO2020210225A1
|
|
Barcoded clonal tracking of gene targeting in cells
|
WO2020190700A1
|
|
Autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer
|
US10684287B1
|
|
Methods related to a structure of high-affinity human PD-1/PD-L2 complex
|
WO2020146899A1
|
|
Targeted in vivo genome modification
|
WO2020106999A1
|
|
High-complexity synthetic gut bacterial communities
|
WO2020086764A1
|
|
Optical real-time biosensor
|
WO2020086762A1
|
|
Compositions and methods involving aptamer switch polynucleotides
|
WO2020081808A1
|
|
Methods and compositions involving thermostable cas9 protein variants
|
WO2020033491A1
|
|
Antibodies against dengue virus and related methods
|
WO2020033438A1
|
|
Nucleic acid sequence enrichment by defined nucleic acid-directed endonuclease digestion
|
WO2020009998A1
|
|
Method to perform high-throughput single cell genomic and phenotypic analyses
|
WO2019236571A1
|
|
Compositions and methods involving non-natural aptamer libraries
|
WO2019236548A1
|
|
Compositions and methods for screening aptamers
|